Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-24-000058
Filing Date
2024-11-07
Accepted
2024-11-07 16:18:47
Documents
99
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20240930x10q.htm   iXBRL 10-Q 2952354
2 EX-10.1 amph-20240930xex10d1.htm EX-10.1 384287
3 EX-31.1 amph-20240930xex31d1.htm EX-31.1 19169
4 EX-31.2 amph-20240930xex31d2.htm EX-31.2 18824
5 EX-32.1 amph-20240930xex32d1.htm EX-32.1 9842
6 EX-32.2 amph-20240930xex32d2.htm EX-32.2 9843
  Complete submission text file 0001297184-24-000058.txt   12594685

Data Files

Seq Description Document Type Size
7 EX-101.SCH amph-20240930.xsd EX-101.SCH 66163
8 EX-101.CAL amph-20240930_cal.xml EX-101.CAL 69349
9 EX-101.DEF amph-20240930_def.xml EX-101.DEF 293577
10 EX-101.LAB amph-20240930_lab.xml EX-101.LAB 515096
11 EX-101.PRE amph-20240930_pre.xml EX-101.PRE 461741
102 EXTRACTED XBRL INSTANCE DOCUMENT amph-20240930x10q_htm.xml XML 2537837
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 241436100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)